Abstract
Pancreatic surgery has been one of the addresses of the most challenging interventions in surgery due to its organ location, neighborhood, and high perioperative morbidity. Pancreatic cancers are generally asymptomatic and among the deadliest cancers. Early diagnosis and management are the most critical factors in the success of the treatment. With the detection of precancerous features of cystic lesions with advanced screening methods, pancreatectomies with various extents and interventional procedures have started to be performed for prophylactic and therapeutic purposes of cystic lesions. In cases where the diagnosis is difficult and risk increases by the remaining lesion, prophylactic resection appears as an option. While nearly 20 different types of cystic lesions are detected in the pancreas, serous cysts, mucinous cysts, intraductal papillary mucinous neoplasias, and solid pseudopapillary tumors constitute 95% of the cases. The majority of pancreatic tumors are sporadic (90%), and 3–10% of the cases are the tumors with a germline (hereditary) transition. The approach to the treatment of sporadic pancreatic tumors is primarily surgical treatment. In hereditary pancreatic tumors, the approach is for prophylactic purposes. In this section, the place of prophylactic surgery in hereditary pancreatic tumors, cystic neoplasms, precursor lesions with benign character, and some miscellaneous conditions are going to be evaluated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bonet T. A guide to the practical physician: shewing, from the most approved authors, both ancient and modern, the truest and safest way of curing all diseases, internal and external, whether by medicine, surgery, or diet. London: Flesher; 1686.
Schnelldorfer T, Adams DB, Warshaw AL, Lillemoe KD, Sarr MG. Forgotten pioneers of pancreatic surgery. Beyond the favorite few. Ann Surg. 2008;247(1):191–202.
Wandesleben FW. Ein Fall von Verletzung des Pancreas. Wochenschr Heilkund. 1845;45:729–32.
Farrell JJ. Prevalence, diagnosis and management of pancreatic cystic neoplasms: current status and future directions. Gut Liver. 2015;9:571–89.
Sun L, Wang Y, Jiang F, Qian W, Shao C, Jin Z. Prevalence of pancreatic cystic lesions detected by magnetic resonance imaging in the Chinese population. J Gastroenterol Hepatol. 2019;34(9):1656–62.
Zerboni G, Signoretti M, Crippa S, Falconi M, Arcidiacono PG, Capurso G. Systematic review and meta-analysis: prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals. Pancreatology. 2019;19:2–9.
Kromrey ML, Bulow R, Hubner J, Paperlein C, Lerch MM, Ittermann T, et al. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut. 2018;67:138–45.
Klöppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology. 2001;1:648–55.
Tanaka M, Fernandez-Del CC, Kamisawa T, Jang JY, Levy P, Ohtsuka T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–53.
Elta GH, Enestvedt BK, Sauer BG, Lennon AM. ACG clinical guideline: diagnosis and management of pancreatic cysts. Am J Gastroenterol. 2018;113:464–79.
European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67(5):789–804.
Bauer F. Pancreatic cystic lesions: diagnostic, management and ındications for operation. Part I. Chirurgia (Bucur). 2017;112(2):97–109.
Costa PRL, Meneses Rêgo AC, Araujo-Filho I. Pancreatic cystic lesions: classification, diagnosis and treatment. Int Surg J. 2016;3(2):443–51.
Aghdassi AA, Mayerle J, Kraft M, Sielenkämper AW, Heidecke CD, Lerch MM. Pancreatic pseudocysts-when and how to treat? HPB (Oxford). 2006;8(6):432–41.
Brugge WR. Diagnosis and management of cystic lesions of the pancreas. J Gastrointest Oncol. 2015;6(4):375–88.
Clores MJ, Thosani A, Buscaglia JM. Multidisciplinary diagnostic and therapeutic approaches to pancreatic cystic lesions. J Multidiscip Health. 2014;7:81–91.
Tyberg A, Kahaleh M. Pancreatic pseudocysts: is shorter duration of drainage an option? Gastrointest Endosc. 2015;82:658–9.
Cooperman AM. Surgical treatment of pancreatic pseudocysts. Surg Clin North Am. 2001;81:411–9.
Aghdassi A, Mayerle J, Kraft M, Sielenkämper AW, Heidecke CD, Lerch MM. Diagnosis and treatment of pancreatic pseudocysts in chronic pancreatitis. Pancreas. 2008;36:105–12.
Mimery A, Pham M, Low WKW, Das A, Rajkomar K. The management of an intraperitoneal leak following transgastric stenting of a pancreatic pseudocyst. Cureus. 2020;12(3):e7236.
Alhassan S, Umar S, Lega M. One of the largest pancreatic pseudocysts in the literature: a case report. Cureus. 2017;9(7):e1493.
Jimenez RE, Fernandez DC, Rattner DW, Warshaw AL. Pylorus-preserving pancreaticoduodenectomy in the treatment of chronic pancreatitis. World J Surg. 2003;27:1211–6.
Assi HA, Mukherjee S, Kunz PL, Machiorlatti M, Vesely S, Pareek V, et al. Surgery versus surveillance for well-differentiated, nonfunctional pancreatic neuroendocrine tumors: an 11-year analysis of the National Cancer Database. Oncologist. 2020;25(2):276–83.
Glascock MJ, Carty SE. Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance. Surg Oncol. 2002;11(3):143–50.
Newey PJ, Thakker RV. Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice. Endocr Pract. 2011;17:8–17.
Wasserman JD, Tomlinson GE, Druker H, Kamihara J, Kohlmann WK, Kratz CP, et al. Multiple endocrine neoplasia and hyperparathyroid-jaw tumor syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res. 2017;23(13):123–32.
Schmid RM, Siveke JT. Approach to cystic lesions of the pancreas. Wien Med Wochenschr. 2014;164:44–50.
Ke N, Jia D, Huang W, Nunes QM, Windsor JA, Liu X, Sutton R. Earlier surgery improves outcomes from painful chronic pancreatitis. Medicine (Baltimore). 2018;97(19):e0651. https://doi.org/10.1097/MD.0000000000010651.
Terris B, Fukushima N, Hruban RH. Serous neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010. p. 296–9.
Colonna J, Plaza JA, Frankel WL, Yearsley M, Bloomston M, Marsh WL. Serous cystadenoma of the pancreas: clinical and pathological features in 33 patients. Pancreatology. 2008;8(2):135–41.
Gurusamy KS, Lusuku C, Halkias C, Davidson BR. Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis. Cochrane Database Syst Rev. 2016;2:CD011521.
Matsumoto T, Hirano S, Yada K, Shibata K, Sasaki A, Kamimura T, et al. Malignant serous cystic neoplasm of the pancreas: report of a case and review of the literature. J Clin Gastroenterol. 2005;39:253–6.
Lee KS, Sekhar A, Rofsky NM, Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol. 2010;105:2079–84.
Tariq MU, Ahmad Z, Abdul-Ghafar J, Din NU. Serous cystadenoma of pancreas: a clinicopathologic experience of 23 cases from a major tertiary care center. Rare Tumors. 2018;10:2036361318809183.
Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandez-del Castillo C. Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg. 2005;242(3):413–9.
Hayek KM, Brown N, O’Rourke C, Falk G, Morris-Stiff G, Walsh RM. Rate of growth of pancreatic serous cystadenoma as an indication for resection. Surgery. 2013;154(4):794–800.
Charlesworth M, Verbeke CS, Falk GA, Walsh M, Smith AM, Morris-Stiff G. Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. J Gastrointest Surg. 2012;16(7):1422–8.
Ketwaroo GA, Mortele KJ, Sawhney MS. Pancreatic cystic neoplasms: an update. Gastroenterol Clin N Am. 2016;45:67–81.
Lekkerkerker SJ, Besselink MG, Busch OR, Verheij J, Engelbrecht MR, Rauws EA, et al. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome. Gastrointest Endosc 2017;85:1025–31.
Raman A, Lennon AM. Cyst fluid biomarkers-diagnosis and prediction of malignancy for cystic lesions of the pancreas. Visc Med. 2018;34(3):178–81.
Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Magginoe L, et al. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut. 2016;65(2):305–12.
Levink I, Bruno MJ, Cahen DL. Management of intraductal papillary mucinous neoplasms: controversies in guidelines and future perspectives. Curr Treat Options Gastroenterol. 2018;16(3):316–32.
Kim SY, Lee JM, Kim SH, Shin KS, Kim YJ, An SK, et al. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor. Am J Roentgenol. 2006;187:1192–8.
Del Chiaro M, Segersvard R, Pozzi Mucelli R, Rangelova E, Kartalis N, Ansorge C, et al. Comparison of preoperative conference-based diagnosis with histology of cystic tumors of the pancreas. Ann Surg Oncol. 2014;21:1539–44.
Demesmaker V, Abou-Messaoud F, Parent M, Vanhoute B, Maassarani F, Kothonidis K. Pancreatic solid serous cystadenoma: a rare entity that can lead to a futile surgery. J Surg Case Rep. 2019;2019(12):rjz360.
Allen PJ, D’Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg. 2006;244:572–82.
Bosman FT, World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010. p. 417.
Tanaka M, Chari S, Adsay V, Fernandez DC, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms ofthe pancreas. Pancreatology. 2006;6:17–32.
Asciutti S, Kanninen TT, Clerici G, Nardi E, Castellani D, DI Renzo GC, et al. Acute pancreatitis with a mucinous cystoadenoma of the pancreas in pregnancy. Anticancer Res. 2010;3:1025–8.
Crippa S, Salvia R, Warshaw AL, Domínguez I, Bassi C, Falconi M, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg. 2008;247:571–9.
Goh BK, Tan YM, Chung YF, Chow PK, Cheow PC, Wong WK, et al. A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients. World J Surg. 2006;30:2236–45.
Furukawa T, Hatori T, Fujita I, Yamamoto M, Kobayashi M, Ohike N, et al. Prognostic relevance of morphological types of intraductal papillarymucinous neoplasms of the pancreas. Gut. 2011;60:509–16.
Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, et al. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014;46(6):479–93.
Nicolas CT, Al Diffalha S, Reddy S. Diffuse histology-proven mucinous cystic neoplasm of the pancreas: a case report and review of literature. Int J Surg Case Rep. 2019;64:123–7.
Vilas-Boas F, Macedo G. Management guidelines for pancreatic cystic lesions: should we adopt or adapt the current roadmaps? J Gastrointestin Liver Dis. 2019;28(4):495–501.
Ohno E, Hirooka Y, Kawashima H, Ishikawa T, Kanamori A, Ishikawa H, et al. Natural history of pancreatic cystic lesions: a multicenter prospective observational study for evaluating the risk of pancreatic cancer. J Gastroenterol Hepatol. 2018;33(1):320–8.
Thornton GD, McPhail MJ, Nayagam S, Hewitt MJ, Vlavianos P, Monahan KJ. Endoscopic ultrasound guided fine needle aspiration for thediagnosis of pancreatic cystic neoplasms: a meta-analysis. Pancreatology. 2013;13:48–57.
Abdelkader A, Hunt B, Hartley CP, Panarelli NC, Giorgadze T. Cystic lesions of the pancreas: differential diagnosis and cytologic-histologic correlation. Arch Pathol Lab Med. 2020;144(1):47–61.
Sun L, Wang W, Wang Y, Jiang F, Peng L, Jin G, et al. Validation of European evidence-based guidelines and American College of Gastroenterology guidelines as predictors of advanced neoplasia in patients with suspected mucinous pancreatic cystic neoplasms. J Gastroenterol Hepatol. 2020;35(9):1644–51. https://doi.org/10.1111/jgh.14973.
Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH, et al. Histological typing of tumours of the exocrine pancreas. In: World Health Organization, editor. International histological classification of tumours. Berlin: Springer; 1996.
Hwang DW, Jang J-Y, Lee SE, Lim CS, Lee KU, Kim SW. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbeck's Arch Surg. 2012;397:93–102.
Duconseil P, Adham M, Sauvanet A, Autret A, Périnel J, Chiche L, et al. Fukuoka-negative branch-duct IPMNs: when to worry? A study from the French Surgical Association (AFC). Ann Surg Oncol. 2018;25:1017–25.
Ridtitid W, DeWitt JM, Schmidt CM, Roch A, Stuart JS, Sherman S, et al. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes. Gastrointest Endosc. 2016;84:436–45.
Abdeljawad K, Vemulapalli KC, Schmidt CM, Dewitt J, Sherman S, Imperiale TF, et al. Prevalence of malignancy in patients with pure main duct intraductal papillary mucinous neoplasms. Gastrointest Endosc. 2014;79:623–9.
Harima H, Kaino S, Shinoda S, Kawano M, Suenaga S, Sakaida I. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography. World J Gastroenterol. 2015;21:6252–60.
Serafini S, Sperti C, Brazzale AR, Cecchin D, Zucchetta P, Pierobon ES, et al. The role of positron emission tomography in clinical management of intraductal papillary mucinous neoplasms of the pancreas. Cancers (Basel). 2020;12(4):E807.
Del Chiaro M, Beckman R, Ateeb Z, Orsini N, Rezaee N, Manos L, et al. Main duct dilatation is the best predictor of high-grade dysplasia or invasion in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2019;272(6):1118–24. https://doi.org/10.1097/SLA.0000000000003174.
Weinberg BM, Spiegel BM, Tomlinson JS, Farrell JJ. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology. 2010;138:531–40.
Coco D, Leanza S, Guerra F. Total pancreatectomy: indication, advantages and disadvantages—a review. Maedica. 2019;14(4):391–6.
Aune D, Greenwood DC, Chan DSM, Vieira R, Vieira AR, Navarro Rosenblatt DA, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose–response metaanalysis of prospective studies. Ann Oncol. 2012;23:843–52.
Vege SS, Ziring B, Jain R, Moayyedi P, Clinical Guidelines Committee, American Gastroenterology Association. American Gastroenterological Association Institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:819–22.
Callahan AF, Ituarte PHG, Goldstein L, Warner SG, Woo Y, Singh G, et al. Prophylactic pancreatectomies carry prohibitive mortality at low-volume centers: a California Cancer Registry Study. World J Surg. 2019;43:2290–9.
Hackert T, Fritz S, Klauss M, Bergmann F, Hinz U, Strobel O, et al. Main-duct intraductal papillary mucinous neoplasm: high cancer risk in duct diameter of 5 to 9mm. Ann Surg. 2015;262:875–81.
Rodriguez-D’Jesus A, Fernandez-Esparrach G, Boadas J, Busquets J, Cruz LF, Ferrere J, et al. Impact of endoscopic ultrasonography (EUS) and EUS-guided fine-needle aspiration on themanagement of pancreatic cystic lesions. Eur J Gastroenterol Hepatol. 2016;28:1094–9.
Suzuki R, Thosani N, Annangi S, Guha S, Bhutani MS. Diagnostic yield of EUS-FNA-based cytology distinguishing malignant and benign IPMNs: a systematic review and meta-analysis. Pancreatology. 2014;14:380–4.
Vanella G, Crippa S, Archibugi L, Arcidiacono PG, Delle Fave G, Falconi M. et al.Meta‐analysis of mortality in patients with high‐risk intraductal papillary mucinous neoplasms under observation. BJS 2018; 105:328–338.
Li J, Yu Y, Zhu L, Li Y, He Q. Magnetic resonance imaging versus computed tomography for biliary tract intraductal papillary mucinous neoplasm (BT-IPMN): a diagnostic performance analysis. Med Sci Monit. 2020;26:e920952. https://doi.org/10.12659/MSM.920952.
Javia S, Munigala S, Guha S, Agarwal B. EUS morphology is reliable in selecting patients with mucinous pancreatic cyst(s) most likely to benefit from surgical resection. Gastroenterol Res Pract. 2017;2017:9863952.
Coccolini F, Kobayashi L, Kluger Y, Moore EE, Ansaloni L, Biffl W, et al. Duodeno-pancreatic and extrahepatic biliary tree trauma: WSES-AAST guidelines. World J Emerg Surg. 2019;14:56.
Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepato-Biliary-Pancreat Surg. 2008;15(1):41–54.
Marsoner K, Langeder R, Csengeri D, Sodeck G, Mischinger HJ, Kornprat P. Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk? Wien Klin Wochenschr. 2016;128:566–72.
Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238(5):720–7.
Klein F, Berresheim F, Felsenstein M, Malinka T, Pelzer U, Denecke T, et al. Routine portal vein resection for pancreatic adenocarcinoma shows no benefit in overall survival. Eur J Surg Oncol. 2018;44(7):1094–9.
Dilek ON, Özşay O, Acar T, Gür EÖ, Çelik SC, Cengiz F, et al. Postoperative hemorrhage complications following the Whipple procedure. Turk J Surg. 2019;35(2):136–41.
Okada K, Murakami Y, Uemura K, Kondo N, Nakagawa N, Seo S, et al. Flooring the major vessels with falciform ligament to prevent post-pancreatectomy hemorrhage. World J Surg. 2020;44(10):3478–85. https://doi.org/10.1007/s00268-020-05637-5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dilek, O.N., Acar, T. (2021). Prophylactic Resections of the Pancreas Pathologies. In: Dilek, O.N., Uranues, S., Latifi, R. (eds) Prophylactic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-66853-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-66853-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-66852-5
Online ISBN: 978-3-030-66853-2
eBook Packages: MedicineMedicine (R0)